Menu
1 min read · estimated
APPROVED USE
What FDA approved
Topical sirolimus for tuberous-sclerosis-associated facial angiofibromas in adults and children age six or older.
LAMPGEN ANALYSIS
Why it matters
The gel provides a localized option for these benign facial tumors.
What research teams should watch
Confirm the tuberous sclerosis diagnosis and age and document the treated lesions and application instructions.
PRIMARY RECORDS